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Immunopathology in RSV Infection Is Mediated
by a Discrete Oligoclonal Subset
of Antigen-Specific CD4 T Cells
RSV is the leading cause of viral lower respiratory
tract infection in infants and young children (Heilman,
1990). Recent studies have demonstrated that RSV is
also an important cause of severe respiratory illness in
elderly and immunocompromised individuals (Dowell et
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Charlottesville, Virginia 22908 al., 1996; Falsey et al., 1992, 1995; Harrington et al., 1992;
Mlinaric-Galinovic et al., 1996). There is currently no safe3 Department of Pathology
4 Program in Immunology and Virology and effective licensed RSV vaccine. A RSV vaccine trial
in the 1960s using formalin-inactivated (FI) RSV resultedUniversity of Massachusetts Medical Center
Worcester, Massachusetts 01655 in enhanced lung disease and, in some cases, death
among vaccine recipients upon subsequent natural RSV
infection (Belshe et al., 1982; Chin et al., 1969; Fulginiti
et al., 1969; Kapikian et al., 1969; Kim et al., 1969). Inter-Summary
estingly, pulmonary eosinophilia were demonstrated in
some of the children who received the FI RSV vaccine,Vaccination with the respiratory syncytial virus (RSV)
suggesting that the FI RSV vaccine had primed themattachment (G) protein results in immune-mediated
for a Th2 response (Chin et al., 1969). It is thereforelung injury after natural RSV infection with pathogenic
imperative to gain a better understanding of the mecha-features characteristic of an exaggerated Th2 re-
nisms that contribute to RSV vaccine-enhanced illnesssponse. Here we demonstrate that approximately half
before a safe and successful vaccine can be developed.of the CD4 T cells infiltrating the lungs of G-primed
mice utilize a single V gene (V14) with remarkably The BALB/c mouse model of RSV infection has proven
limited CDR3 diversity. Furthermore, elimination of to be a valuable tool in dissecting the mechanisms of
these V14-bearing CD4 T cells in vivo abolishes the vaccine-enhanced disease (Graham et al., 1988). The
type 2-like pulmonary injury. These results suggest enhanced lung pathology, including pulmonary eosino-
that a novel subset of CD4 T cells may be crucial philia, exhibited by the children who received the FI RSV
in the development of pathology during human RSV vaccine can be simulated by priming BALB/c mice with
infection and that genetic or environmental factors FI RSV (Connors et al., 1992; Graham et al., 1993) or a
prior to or at the time of G antigen exposure may affect recombinant vaccinia virus (vv) expressing the G glyco-
the commitment of this discrete antigen-specific T cell protein of RSV (Openshaw et al., 1992) followed by intra-
subset to Th2 differentiation. nasal inoculation with infectious RSV. Studies using the
BALB/c animal model have demonstrated that RSV
Introduction G-specific CD4 T cells that secrete Th2 cytokines are
not only responsible for mediating the pulmonary eosin-
CD4 T cells play a critical role in regulating immune ophilia, but for enhanced weight loss and illness as well
responses and can dramatically affect the balance be- (Alwan et al., 1994; Johnson and Graham, 1999; Johnson
tween host defense and immunopathology to a wide et al., 1998; Openshaw et al., 1992; Srikiatkhachorn and
range of intracellular pathogens. CD4 T cells direct the Braciale, 1997; Waris et al., 1996).
immune response through the secretion of cytokines Despite the importance of RSV G-specific CD4
and can occur as two distinct subsets based on their T cells in mediating enhanced disease, there is surpris-
production of particular cytokines: Th1 CD4 T cells ingly little known regarding the specificity and diversity
produce IFN- and TNF-, whereas Th2 CD4 T cells of the RSV G-specific CD4 T cell response. We have
make IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13 (Janeway et recently mapped the response of BALB/c mice to a
al., 1988; Mosmann et al., 1986; Mosmann and Coffman, single immunodominant I-Ed-restricted CD4 T cell epi-
1989; Mosmann et al., 1991; O’Garra, 1998). In many tope within the G protein of RSV (Varga et al., 2000). In
cases, the relative balance of CD4 T cells that actively the present study, we demonstrate that the majority of
secrete Th1 versus Th2 cytokines determines the out- RSV G-specific memory effector CD4 T cells that have
come and severity of the disease. For example, during entered the lung following pulmonary RSV infection ex-
virus infections, Th1 CD4 T cell responses generally press the V14 T cell receptor (TCR) with remarkably
favor enhanced virus clearance, whereas Th2 cell re- limited diversity within the complement determining re-
sponses can prolong virus replication and, in some gion 3 (CDR3) of the TCR of the V14 T cells between
cases, can lead to enhanced immunopathology (Alwan infected individuals. Because the majority of the RSV
et al., 1994; Fischer et al., 1997; Graham et al., 1991; G-specific CD4 T cells express a V14 TCR, we ques-
Graham et al., 1994; Maloy et al., 2000; Tang and Gra- tioned the role of these cells in mediating RSV vaccine-
ham, 1997). In particular, the murine model of respiratory enhanced immunopathology. We show here that BALB/c
syncytial virus (RSV) has proven invaluable in studying mice depleted of V14 cells in vivo, either at priming
the effect of CD4 T cell subsets on the immune response with RSV G or at challenge infection, fail to develop
and pathogenesis during virus infection (Hussell and enhanced disease including systemic illness, weight
Openshaw, 1999; Neuzil and Graham, 1996). loss, and pulmonary eosinophilia following experimental
RSV infection. These results demonstrate that RSV vac-
cine-enhanced immunopathology is uniquely restricted5 Correspondence: tjb2r@virginia.edu
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Figure 1. Intracellular IFN- Expression of
RSV G Peptide-Specific V14 CD4 T Cells
Lung mononuclear cells from a pool of four
vvgal or four vvG-primed mice 5 days after
RSV infection were stimulated with RSV G
183-195 peptide or left unstimulated in the
presence of brefeldin A for 5 hr. Representa-
tive V14/IFN- costaining for the CD4-gated
populations are shown. Percentages in the
indicated quadrants represent the percent-
age of gated CD4 cells that fall within each
quadrant. Data shown are representative of
three separate experiments with a pool of four
mice per experiment.
to a discrete oligoclonal CD4 T cell population and V14CD4 T cells in the lung was 27-fold higher in vvG-
primed mice 5 days after RSV infection than in infectedsuggests that the commitment of virus-specific CD4
T cells to Th2 differentiation may be dictated by TCR vvgal-primed control mice. The increase in the total
number of epitope-specific V14CD4 T cells in theusage and regulated by genetic or environmental factors
operating on the naive CD4 T cells at the time of initial lung was even more impressive with an 864-fold expan-
sion relative to the level of vvgal-primed control mice.exposure to specific viral antigen.
These results demonstrate that V14 T cells are highly
enriched among RSV G peptide-specific CD4 T cells.Results
We also examined TNF- production by lung-infiltrat-
ing memory CD4 T cells responding to the immuno-Accumulation and TCR V Usage of Lung-Derived
dominant G 183-195 epitope. Consistent with recentlyRSV G-Specific Memory Effector CD4 T Cells
published observations (Slifka and Whitton, 2000), weWe first examined the frequency of CD4 T cells isolated
found that G-specific memory effector CD4 T cells pro-from RSV-infected lungs that expressed the V14 TCR
duce high levels of both TNF- and IFN- (Figure 2).and were capable of making IFN- following short-term
Importantly, the majority of these dual TNF-/IFN--in vitro stimulation with the recently described immuno-
secreting CD4 T cells in the lung are V14. This sug-dominant RSV G 183-195 peptide (Varga et al., 2000).
gests that the systemic symptoms, including weightFigure 1 shows a representative analysis of V14 and
loss, associated with TNF- production in G-primedIFN- expression of gated lung-infiltrating CD4 T cells
mice undergoing challenge RSV infection may be linkedfrom a pool of four control (vvgal-primed) or vvG-primed
to cytokine production by CD4 T cells expressing theBALB/c mice 5 days after RSV infection. In control mice
V14 TCR.undergoing a primary RSV infection (vvgal-primed
To determine the contribution of effector V14CD4group), there was a very low frequency of RSV G peptide-
T cells to the Th2 cytokine response, we measured IL-4,specific CD4 T cells in the lung at day 5 p.i. and 10%
IL-5, IL-13, and IFN- protein levels in 48 hr cultureof the CD4 T cells in the lung expressed a V14 TCR
supernatants of lung mononuclear cells stimulated with(Figure 1). In contrast, 64% of the CD4 T cells secre-
anti-TCR antibodies. As Figure 3 demonstrates, theting IFN- in response to the dominant G 183-195 epi-
V14CD4 T cell population infiltrating the infectedtope expressed V14, and the V14 T cells represent
lung contains cells capable of making the Th1-associ-35% of the total CD4 T cells infiltrating the lungs of
ated cytokine IFN- as well as the Th2-associated cyto-G-primed mice at day 5 p.i. Figure 1 also demonstrates
kines IL-4, IL-5, and IL-13. Because we have previouslythe dramatic increase in the total number of lung-infil-
demonstrated that both IL-5 and IL-13, but not IL-4, aretrating V14CD4 T cells that occurs after pulmonary
RSV infection of G-primed mice. The total number of produced following stimulation with the RSV G 183-195
Oligoclonal CD4 T Cells during RSV Infection
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Figure 2. Intracellular IFN- and TNF- Ex-
pression of Lung-Derived Memory Effector
CD4 T Cells
Lung mononuclear cells from a pool of four
vvG-primed mice 5 days after RSV infection
were stimulated with RSV G 183-195 peptide
in the presence of brefeldin A for 5 hr. Cells
were stained for expression of CD4, V14,
IFN-, and TNF-. Representative CD4/V14
costaining is shown. The right panels repre-
sent IFN- and TNF- costaining on the two
gated populations. Percentages in the indi-
cated quadrants represent the percentage of
the gated cells that fall within each quadrant.
Data shown are representative of three sepa-
rate experiments with a pool of four mice per
experiment.
peptide, and because stimulation with anti-V14 mAb Oligoclonal CDR3-Restricted Expansions
within the V14CD4 T Cell Populationaccounted for a high proportion of the IL-5 and IL-13,
it is likely that a concomitantly high proportion of the It is possible that there would be considerable heteroge-
neity within the CDR3 region of the lung-infiltratingRSV G peptide-specific Th2 cells are contained within
the V14CD4 T cell population. It is unlikely that CD8 V14CD4 T cell population. Such heterogeneity, for
example, has been seen in LCMV-induced CD8 T cellT cells contribute significantly to the Th2 cytokine pro-
duction demonstrated in Figure 3 because there is not populations expressing distinct Vs (Lin and Welsh,
1998; Lin et al., 2000). To examine the clonal diversitya significant influx of CD8 T cells that express the V14
TCR into the lung (data not shown) and, because to of the CD4 T cells infiltrating the lung, we performed
CDR3-length spectratyping analysis on the V14 T celldate, there has not been any evidence for a type 2 CD8
T cell response during RSV infection in the mouse. population. We consistently observed skewed spec-
tratypes of varying magnitudes within nearly all of the
12 functional J-defined windows of the V14 T cell
response; this contrasted with V14 spectratypes from
uninfected control mouse lung and spleen, which
showed Gaussian distributions of CDR3 lengths within
each of the J windows. Our analysis of eight individual
mice showed that strong dominant peaks were often
found within the J1.1 (8/8), J2.2 (5/8), J1.4 (4/8),
and J1.5 (3/8) windows. Figure 4A shows the complete
V14 spectratype of a mouse that had dominant J1.1
and J2.2 peaks. Because V14-J1.1 spectratypes of
the same CDR3 length were dominant in each of the eight
mice examined, we further analyzed them by DNA se-
quence analysis. This analysis revealed identical CDR3
regions in four of the mice examined, with a LRANTEVF
amino acid sequence and minimal residue substitution
within this CDR3 among the four other mice examined
(Figure 4B). The alanine in the third position was also
conserved in the J2.2 spectratypes of six of the seven
sequenced (data not shown). These results demonstrate
that between individual BALB/c mice, there is limited
TCR diversity and, in some cases, V clonal identity
within the RSV G-induced CD4 T cell response.
Figure 3. Th1 and Th2 Cytokine Production by V14 CD4 T Cells
Lung mononuclear cells were isolated from four individual vvG- Depletion of V14 T Cells Prevents Enhanced
primed mice 5 days after RSV infection and stimulated in vitro with Disease and Pulmonary Eosinophilia in G-Primed
platebound anti-V14 or anti-TCR mAb for 48 hr. The cytokine
Mice Challenged with RSVconcentration in the supernatant was determined for the given cyto-
BALB/c mice previously primed with vvG exhibit en-kines by ELISA. One representative from three separate experiments
is shown. hanced systemic illness, weight loss, and pulmonary
Immunity
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Figure 4. CDR3-Length Spectratypes of V14 Cells and Dominant Usage of T Cell Repertoire in BALB/c Mice
(A) CDR3 profiles of the V14-J runoff products from a G-primed, RSV-infected mouse. Total RNAs were extracted from lung lymphocytes
5 days after infection and subjected to spectratyping analysis. Fluorescent intensity (y axis) was plotted against relative CDR3 size (x axis).
(B) Similar V14-J1.1 TCR sequences after infection. PCR products from eight individual mice were sequenced. Amino acid sequences of
the V14-J1.1 were deduced from DNA sequences. In mouse #6, the DNA sequence data showed that either of two amino acids were
encoded by what were probably at least two clones, and they are designated in the A/B format.
eosinophilia after intranasal challenge with RSV. To de- treated, 41  8; anti-V14 treated, 22  8; n  4 per
termine the contribution of the V14CD4 T cell popu- group; p  0.05). However, the percentage of CD4 T
lation in mediating the enhanced immunopathology, we cells capable of making IFN- following the polyclonal
depleted V14 cells in vivo at the time of RSV challenge stimulus phorbol myristate acetate and ionomycin was
in G-primed BALB/c mice. Figure 5 shows that depletion not significantly different between the anti-V14-treated
of V14 T cells reduced systemic illness scores, weight and rat IgM-treated control mice (Figure 6C; rat IgM
loss (p 0.05; days 2–5 p.i.), and pulmonary eosinophilia treated, 64  5; anti-V14 treated, 56  6; n  4 per
(p  0.05) in G-primed mice challenged with RSV. The group; p  0.05). This difference may be explained by
remaining illness, weight loss, and eosinophilia exhib- the emergence of a T cell population specific to a sub-
ited by mice that have been depleted of V14 cells dominant CD4 T cell epitope within RSV G that would
resembles the small amount of disease that occurs dur- be detected following a polyclonal stimulus and not fol-
ing primary RSV infection of unprimed or control primed lowing activation with the immunodominant RSV G 183-
mice (Johnson et al., 1998; Sparer et al., 1998). To evalu- 195 peptide. In addition, total lung leukocyte counts
ate the effectiveness of the antibody treatment, we mon- were not significantly different between the two groups,
itored the frequency of antigen-specific V14CD4 suggesting that the observed differences in immunopa-
T cells by flow cytometry from the lungs of treated or
thology were not due to a difference in the extent of
control mice (n  4/group). V14 cells constituted
pulmonary inflammation (data not shown). These results44%  10% of the CD4 T cells in the lungs of nonde-
are consistent with recent work demonstrating the im-pleted control infected mice but only 2%  1% in de-
portance of IFN--secreting Th1 cells in regulating pul-pleted mice. Thus, the anti-V14 treatment caused a
monary inflammation (Cohn et al., 1999). We observed95% reduction in the frequency of V14CD4 T cells.
similar results at day 7 p.i., suggesting that the aboveFigure 6A shows a representative analysis of V14 and
differences were not simply due to a delay in the kineticsIFN- expression of gated CD4 T cells from rat IgM-
of the response (data not shown). It is unlikely that anytreated or anti-V14-treated G-primed BALB/c mice 5
of the above differences are due to differences in virusdays after RSV infection. Interestingly, anti-V14 treat-
titers between the two groups since G-primed mice clearment significantly reduced the percentage of CD4 T
virus more rapidly, and the development of enhancedcells that were capable of making IFN- following RSV
G 183-195 peptide stimulation (Figure 6B; rat IgM disease is not associated with enhanced virus replica-
Oligoclonal CD4 T Cells during RSV Infection
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tion, but rather, with the development of a strong T cell
response in this model system.
Depletion of V14 T Cells during vvG Priming
Prevents Enhanced Disease and Pulmonary
Eosinophilia Following RSV Challenge
The above results implied that RSV G-specific memory
effector CD4 T cells displaying the V14 TCR mediated
the enhanced disease and pulmonary eosinophilia in-
duced by challenge RSV infection. It was of interest to
determine if, within the naı¨ve pool of RSV G-specific
CD4 T cell precursors, V14CD4 T cells were the
predominant source of memory effector Th2 CD4
T cells mediating the enhanced disease. Because the
above depletions were performed at the time of RSV
challenge after the memory CD4 T cell repertoire had
become fixed, we were unable to determine whether
or not in the absence of V14 T cells another RSV
G-specific memory CD4 T cell population could also
mediate enhanced disease. Therefore, to further exam-
ine the importance of the V14CD4 population in the
development of vaccine-enhanced immunopathology,
we depleted these cells in vivo at the time of the vvG
priming. As shown in Figure 7, anti-V14 treatment at
the time of vvG priming reduced systemic illness, weight
loss, and pulmonary eosinophilia following RSV chal-
lenge much like we observed above for anti-V14 treat-
ment at RSV challenge. Again, the total lung leukocyte
counts of both groups were comparable, and similar
results were observed at day 7 p.i. (data not shown).
These results suggest that no other CD4 T cells in the
naı¨ve T cell repertoire respond in the same manner as
RSV G-specific CD4 T cells that express the V14 TCR.
They also suggest that the ability to cause enhanced
disease and the implicated Th2 response reside within
this discrete oligoclonal RSV G-specific V14CD4
T cell population, which becomes committed to the Th2
differentiation pathway.
Discussion
The BALB/c mouse model of RSV infection has proven to
be a powerful tool in dissecting the role of various cell
populations and the underlying mechanisms at work in
mediating vaccine-enhanced disease and immunopathol-
ogy. Previous studies have clearly demonstrated that en-
hanced disease is associated with the development of
virus-specific Th2 CD4 T cells that secrete IL-4, IL-5, and
IL-13 (Alwan et al., 1994; Johnson and Graham, 1999;
Johnson et al., 1998; Openshaw et al., 1992; Srikiatkha-
chorn and Braciale, 1997; Waris et al., 1996). In the current
study, we analyzed the TCR repertoire of CD4 T cells
responding against the G glycoprotein of RSV using a
recently defined immunodominant epitope to identify RSV
G-specific CD4 T cells (Varga et al., 2000). Our currentFigure 5. V14 Depletion at the Time of RSV Challenge Infection
results clearly demonstrate that the CD4 T cell responsePrevents RSV Vaccine-Enhanced Disease
directed against the immunodominant RSV G 183-195 epi-Mice were primed with vvG and challenged with RSV 21 days later.
One group of four mice received anti-V14 mAb at days 	1 and 2 tope is highly skewed with 60% of the antigen-specific
relative to RSV challenge, whereas a second group received purified cells utilizing a highly conserved V14 TCR. In addition,
rat IgM mAb as a control. Representative data from one of three
separate experiments with four individual mice per experiment are
shown.
(A) Mean illness scores  SD from four individual mice per group. challenge on the basis of the original weight of each mouse.
(B) Weight loss was monitored daily following RSV challenge. The (C) Mean BAL eosinophil percentages  SD from four individual
percent weight loss was calculated on subsequent days after RSV mice per group.
Immunity
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Figure 6. Intracellular IFN- Expression of RSV G Peptide-Specific V14 CD4 T Cells in Rat IgM or V14-Treated Mice
Lung mononuclear cells isolated 5 days after RSV infection from four individual G-primed mice that had received either anti-V14 or rat IgM
as a control.
(A) Representative V14/IFN- costaining on the CD4-gated population following stimulation with the RSV G 183-195 peptide in the presence
of brefeldin A for 5 hr.
(B) Representative IFN- staining for RSV G 183-195 epitope-specific CD4 T cells.
(C) Representative IFN- staining following PMA and ionomycin activation of the CD4 T cells. Contour plot analyses are shown using 5%
probability curves. Data shown are representative of three separate experiments with four mice/group per experiment.
we provide evidence for oligoclonal expansions within the It is well established that many different T cell clono-
types typically contribute to the response to a singleV14 population, as shown by the consistent use of
V14-J1.1 as well as CDR3 sequence data showing antigenic epitope. In addition, a single TCR is capable
of recognizing multiple peptide ligands (Evavold et al.,highly conserved motifs among individual mice. Further-
more, we demonstrate that CD4 T cells expressing this 1993). This plasticity in the TCR ensures that the immune
system can respond to a multitude of foreign pathogenicrestricted V14 repertoire are responsible for mediating
RSV vaccine-enhanced disease. organisms. Our results demonstrate that the RSV
Oligoclonal CD4 T Cells during RSV Infection
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G-specific CD4 T cell repertoire, responding in the
lungs to RSV infection, is constrained in both its TCR
V usage and in its CDR3 region. This contrasts with
previous work that demonstrated a great deal of CDR3
length and sequence diversity during the peak of a virus-
induced CD8 T cell response (Blattman et al., 2000;
Lin and Welsh, 1998). However, such limited T cell reper-
toires have previously been described for the LACK anti-
gen of Leishmania major and the protein antigen pigeon
cytochrome c (McHeyzer-Williams et al., 1999; Reiner
et al., 1993). In the L. major system, CD4 T cells specific
to the Leishmania homolog of mammalian RACK1, des-
ignated LACK, utilize a highly conserved V4/V8 TCR
and have been shown to produce the burst of IL-4 that
skews the immune response toward a Th2-type in suscep-
tible mouse strains resulting in a pathologic nonhealing
progressive disease (Launois et al., 1997). Interestingly,
recent evidence suggests that this highly restricted CD4
T cell population responsible for the early IL-4 produc-
tion in response to the LACK antigen may in fact be
memory Th2 CD4 T cells that crossreact with a bacteria
found in the gut (Julia et al., 2000). It is unlikely that a
precommitted Th2 memory CD4 T cell population
would account for the strong V14 RSV G-specific
CD4 T cell response that we have demonstrated here
since mice primed with a control vector (vvgal) do not
exhibit the same expansion of V14CD4 T cells or
exhibit lung eosinophilia and enhanced disease follow-
ing pulmonary RSV infection.
Although the highly focused RSV G-specific CD4
T cell response resembles the highly restricted CD4
T cell response that occurs during L. major infection,
there are several important differences. The Th2-biased
immune response that develops following L. major infec-
tion of BALB/c mice is IL-4 dependent (Kopf et al., 1996;
Sadick et al., 1990). In contrast, recent work has clearly
demonstrated that the development of pulmonary eosin-
ophilia, enhanced illness, and IL-5 and IL-13 production
in the lung is unaltered in G-primed mice that have been
depleted of IL-4 in vivo (Johnson and Graham, 1999;
Johnson et al., 1998). Thus, unlike the LACK antigen of
L. major, the G protein of RSV is able to induce Th2
CD4 T cells through an IL-4-independent mechanism.
In addition, recent work has suggested that residues
within the TCR that interact with major histocompatibility
complex-bound peptides can affect the Th1/Th2 differ-
entiation of naı¨ve CD4 T cells (Blander et al., 2000). We
have shown in this report that there is substan-
tial conservation within the V CDR3 region of the
V14CD4T cells within the lung. This result, along with
our finding of the requirement for V14CD4 T cells
in the development of enhanced disease both during
challenge virus infection and at the time of priming,
suggests that this unique oligoclonal CD4 T cell popu-Figure 7. V14 Depletion during G Priming Prevents the Subse-
lation may already be committed to develop into Th2quent Development of RSV Vaccine-Enhanced Disease
memory effector cells at the time of their initial encounterMice were primed with vvG and challenged with RSV 21 days later.
with the antigen. This concept is supported by previousOne group of four mice received anti-V14 mAb at days 	1, 4,
and 8 relative to scarification with vvG, whereas a second group work showing that primary immunization with a synthetic
received purified rat IgM mAb as a control. Representative data
from one of three separate experiments with four individual mice
per experiment are shown.
(A) Mean illness scores  SD from four individual mice per group. challenge on the basis of the original weight of each mouse.
(B) Weight loss was monitored daily following RSV challenge. The (C) Mean BAL eosinophil percentages  SD from four individual
percent weight loss was calculated on subsequent days after RSV mice per group.
Immunity
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peptide containing the immunodominant G 183-195 epi- time of T cell priming suggests that this unique popula-
tope employed here results in pulmonary eosinophilia tion of RSV G-specific CD4 T cells may already be
and enhanced illness following challenge RSV infection destined (programmed), as naı¨ve precursor T cells, to
(Tebbey et al., 1998). It is also possible that the RSV give rise to Th2 memory effector T cells at the time of
G protein itself directly promotes the Th2 CD4 T cell initial encounter with the antigen. Our results also raise
differentiation of naı¨ve precursor T cells as a soluble the possibility that the enhanced pulmonary injury ob-
secreted form of the membrane G glycoprotein and can served in recipients of the FI RSV vaccine after natural
be released from infected cells. A recent report has RSV infection may be due to the induction of memory
demonstrated that mice primed with the secreted form CD4 T cells in these vaccinated children, which were
of G exclusively develop greater eosinophilia, weight likewise of limited TCR diversity and programmed to
loss, and systemic illness after RSV challenge than mice differentiate into Th2 effectors in response to natural
primed with the membrane anchored form of G (Johnson infection. Since, in children, primary and in some in-
et al., 1998). If a novel structural feature of the RSV stances secondary RSV infection can produce severe
G protein does facilitate CD4 Th2 differentiation, the illness, it is tempting to speculate that RSV-specific Th2
results reported here suggest that V14CD4 T cells CD4 T cells may play a crucial role in orchestrating
are uniquely sensitive to the differentiation stimulus pro- disease severity. The findings reported here strongly
vided by the G protein. suggest that further analysis of the repertoire and diver-
Our results also imply that Th2 cytokines other than sity of CD4 T cells in the respiratory tract during human
IL-4, such as IL-5 and IL-13, play an important role in RSV infection is necessary to gain a better understand-
mediating the enhanced disease observed in G-primed ing of RSV-induced immunopathology.
mice. IL-5 has been shown to be important in the pro-
Experimental Proceduresduction, activation, and recruitment of eosinophils. It is
likely that IL-5 production by RSV G-specific CD4
Mice and Virus StocksT cells drives the pulmonary eosinophilia. The cytokines
Six- to eight-week-old female BALB/cAnNTac (H-2d) mice were pur-important in inducing systemic illness and weight loss in
chased from Taconic Farms (Germantown, NY). Mice were housed
G-primed mice remain unclear. In a number of systems, in a specific pathogen-free environment. Recombinant vv express-
CD4 T cells that produce high levels of TNF- can ing the attachment (vvG) glycoprotein of RSV was a kind gift of J.L.
mediate enhanced weight loss. We have shown here Beeler (Food and Drug Administration, National Institutes of Health).
Recombinant vv expressing -galactosidase (vvgal) was used asthat the majority of RSV G-specific CD4 T cells that
a negative control. The A2 strain of RSV was a generous gift frommake IFN- also make TNF-. However, G-primed mice
P.L. Collins (National Institute of Allergy and Infectious Diseases,that were depleted of V14 T cells at RSV challenge
National Institutes of Health). RSV was grown in HEp-2 cells (Ameri-
had only a 2-fold reduction in the frequency of RSV G can Type Culture Collection, Manassas, VA).
peptide-specific CD4 T cells that could make IFN-,
and there was no significant reduction in the frequency Mouse Infection and Antibody Treatment
of CD4T cells that could make IFN- following stimulation Mice (four mice per group) were scarified at the base of the tail with
3 
 106 pfu of vvgal or vvG in a final volume of 10 l. Three weekswith PMA and ionomycin. Because depletion of V14
later, mice were challenged intranasally with 5 
 106 pfu of RSV. ToT cells significantly reduced both systemic illness and
deplete cells at RSV challenge, mice were injected i.p. with 100 gpulmonary eosinophilia, it is possible that one or more
of anti-V14 mAb or purified Rat IgM (BD Pharmingen, San Diego,
Th2 cytokines released specifically by RSV G-specific CA) in a volume of 200 l in PBS at days 	1 and 2 relative to RSV
V14CD4 T cells induce the systemic illness and challenge. To deplete cells at vvG priming, mice were injected i.p.
weight loss that occurs in G-primed mice after RSV with 100 g of anti-V14 mAb or purified Rat IgM in a volume of
200 l in PBS at days 	1, 4, and 8 relative to scarification withinfection. A role for Th2 cytokines in the development
vvG. Mouse weights and illness scores were monitored daily. Illnessof systemic illness is supported by our observation that
was scored using a standard scale: 0  healthy; 1  slightly ruffleddepletion of V14 T cells inhibited weight loss and
fur; 2 ruffled fur but active; 3 ruffled fur and inactive; 4 ruffledsystemic illness after RSV challenge even though the
fur, inactive, and hunched; and 5  dead. Mice were sacrificed by
V14-depleted mice generated a strong RSV G-specific cervical dislocation at day 5 or 7 after RSV challenge.
Th1 CD4 T cell response. Our conclusions are further
supported by recent work demonstrating reduced pul- Peptides
monary eosinophilia and weight loss in G-primed mice Peptides derived from hen egg lysozyme (HEL) 108-119
(WVAWRNRCKGTD) (Katz et al., 1982) and RSV G 183-195 (WAICKafter depletion of CD4 T cells expressing T1/ST2 (Walzl
RIPNKKPG) (Varga et al., 2000) were used in the intracellular cyto-et al., 2001), an orphan receptor expressed on Th2 cells
kine assays. All peptides were synthesized by the University ofat the time of challenge RSV infection (Coyle et al., 1999;
Virginia Biomolecular Research Facility using standard techniquesXu et al., 1998).
of F-moc chemistry.
The results reported here demonstrate that during the
acute phase of the host immune response to pulmonary Bronchoalveolar Lavage
virus infection, an oligoclonal population of effector Bronchoalveolar lavage (BAL) was performed by cannulation of the
CD4 T cells represents the predominant effector T cell trachea and lavage with three successive washes with 1 ml of PBS.
Cytospin (Cytospin 2; Cytospin, Shandon, Pittsburgh, PA) prepara-population accumulating at the primary site of infection.
tions of BAL cells from each individual mouse were stained withIn the case of experimental RSV infection, this effector
Diff-Quik (Baxter Healthcare, Miami, FL), and differential cell countsCD4 T cell population plays a central role in orchestrat-
were performed on 300 cells based on morphology and staining
ing the enhanced illness and Th2-driven immunopathol- characteristics. Isolation of lung mononuclear cells was performed
ogy observed during challenge RSV infection of RSV after BAL and perfusion of blood from the lungs through the right
G-primed mice. Furthermore, the requirement for V14 ventricle using 5 ml of PBS containing 10 U/ml of heparin (Sigma,
St. Louis, MO).T cells in the development of enhanced disease at the
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